通过增强脂生和Ran激活,促进前列腺癌的进展和割抵抗
Yiheng Dai1, Lilong Liu2, Yongbo Luo1
1First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Cancer research
|August 27, 2025
概括
在前列腺癌 (PCa) 中增加的马洛尼尔-CoA通过促进脂质生成和修改蛋白质来促进瘤生长和药物耐药性. 针对马洛尼尔-CoA途径为PCa提供了潜在的治疗策略.
科学领域:
- 生物化学
- 癌症学
- 代谢途径
背景情况:
- 马洛尼尔-CoA是调节脂肪生成和脂肪酸氧化的关键代谢物.
- 癌细胞表现出改变的代谢状态,这表明马洛尼尔-CoA在瘤发育和药物耐药性中的作用.
- 前列腺癌 (PCa),特别是抵抗割的PCa (CRPC),其特征是脂质代谢异常.
研究的目的:
- 在前列腺癌进展和药物耐药性中研究马洛尼尔-CoA积累的作用.
- 探索向PCa中的malonyl-CoA途径的治疗潜力.
主要方法:
- 在PCa组织中量化马洛尼尔-CoA水平.
- 对马洛尼尔-CoA对脂质生成,内分泌网膜平衡和线粒体功能的影响进行分析.
- 研究马洛尼尔-CoA脱碳酶 (MLYCD) 表达及其对未折叠蛋白质反应的影响.
- 评估氨酸化,特别是Ran K141及其对雄激素受体活性的影响.
主要成果:
- 在PCa中,尤其是CRPC中,马洛尼尔-CoA水平较高.
- 累积的malonyl- CoA促进了脂质生成,ER稳定和线粒体功能,推动了PCa的进展.
- 恢复MLYCD通过消耗马洛尼尔-CoA激活了未折叠的蛋白质反应.
- 促进Ran K141的lysine malonylation,增强其活性和雄激素受体信号,有助于PCa的发展和抗雄激素耐药性.
结论:
- 通过代谢调节和蛋白质化,马洛尼尔-CoA在PCa的进展中起着重要作用.
- 马洛尼尔-CoA轴是前列腺癌的潜在生物标志物和治疗点.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:24Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K